Greenstone Biosciences, Inc. and Intel Corp. Launch Strategic Collaboration to Scale Human-Centric Drug Discovery
Greenstone Biosciences, Inc. announces a collaboration with Intel Corp. (
NASDAQ: INTC) to accelerate AI-enabled drug discovery using Greenstone’s large-scale, human biobank of induced pluripotent stem cells and Intel’s Edge AI advanced computing and AI infrastructure. Intel and Greenstone are working together to speed up the development of new medicines. The collaboration combines state-of-the-art human genetics and biology from Greenstone with Intel purpose-built silicon – to scale data processing, storage, and analysis. Greenstone has built the world’s largest human biobank of induced pluripotent stem cells (iPSC).
